FDA Completes Inspection Of J&J Vaccine Maker Emergent BioSolutions, Cites Concerns Over Cross-Contamination, SanitationThe U.S. Food and Drug Administration has completed its inspection of the Baltimore-based Johnson & Johnson vaccine maker Emergent BioSolutions Tuesday and "cited a number of observations concerning whether the facility’s processes met our requirements and standards."
Investigation Launched Into Whether Johnson & Johnson Vaccine Maker Used Tie With Trump Official To Profit From Federal ContractsThe House Committee on Oversight and Reform has launched an investigation into whether Baltimore-based Johnson & Johnson COVID-19 vaccine maker Emergent BioSolutions leveraged a tie with a Trump administration official to profit from federal contracts.
Johnson & Johnson COVID Vaccine Maker Emergent BioSolutions Asked To Stop Making Doses While FDA Investigation UnderwayEmergent BioSolutions, the Baltimore, Maryland-based company manufacturing the Johnson & Johnson coronavirus vaccines, was asked to stop manufacturing COVID-19 related products, while the Food & Drug Administration continues its investigation into quality control issues at the plant that ruined 15 million potential doses of the vaccine.
Johnson & Johnson To 'Assume Full Responsibility' Manufacturing Drug Substance For COVID Vaccine At Emergent BioSolutionsJohnson & Johnson is assuming full responsibility regarding the manufacturing of drug substance for its COVID-19 vaccine at Emergent BioSolutions in Baltimore, the company announced Saturday.
Amid Calls For Transparency, Emergent CEO Says Workers Did Not Accidentally Mix Johnson & Johnson, AstraZeneca VaccinesRobert Kramer, the CEO of Emergent BioSolutions, said in an interview with CNBC that he wanted to clear up “misunderstandings and misconceptions” about what happened at the company’s Baltimore facility last month when millions of Johnson & Johnson vaccine doses were reportedly ruined.
Hogan: ‘Major Screw Up’ At Baltimore Vaccine Facility Ruined 15 Million Johnson & Johnson Doses; Emergent Defends Record Following Report of Past IssuesMaryland Governor Larry Hogan said he learned yesterday along with the public about the mix-up at Baltimore’s Emergent BioSolutions plant weeks ago that reportedly ruined almost 15 million doses of the Johnson & Johnson vaccine.
‘Human Error' At Baltimore Facility Ruined Millions of Johnson & Johnson Vaccine Doses, Report Says“Human error” at Emergent BioSolutions’ highly-touted vaccine facility in Baltimore may have ruined 15 million doses of the Johnson & Johnson vaccine, according to a report Wednesday in the New York Times.
President Joe Biden's Visit To Emergent BioSolutions' Baltimore Lab CanceledPresident Joe Biden will not visit the Emergent BioSolutions' lab in Baltimore this week.
Update: President Biden Won't Be Visiting Baltimore Lab Making Johnson & Johnson VaccinePresident Joe Biden is scheduled to visit Baltimore next week, the White House confirmed Friday.
Gov. Hogan Says Johnson & Johnson COVID Vaccine, Made In Baltimore, Could Be 'Major Breakthrough' To Increase SupplyState officials expressed optimism Thursday a COVID-19 vaccine candidate from Johnson & Johnson that is being manufactured in Baltimore will get emergency use authorization from the U.S. Food and Drug Administration.
‘Game-Changer’ | Inside The Baltimore Lab Producing Johnson & Johnson, AstraZeneca COVID-19 VaccinesWJZ gets an exclusive look inside the Baltimore lab producing Johnson & Johnson's one dose COVID-19 vaccine.
Johnson & Johnson Asks US Regulators To OK Its One-Shot COVID-19 VaccineJohnson & Johnson asked U.S. regulators Thursday to clear the world's first single-dose COVID-19 vaccine, an easier-to-use option that could boost scarce supplies.
Single-Dose Johnson & Johnson COVID-19 Vaccine Would Be A 'Game Changer,' Maryland Officials SayAs states desperately await for more doses of the limited coronavirus vaccines created by Pfizer and Moderna, Maryland Gov. Larry Hogan is hoping that another company will begin producing their version of their COVID-19 vaccine soon.
Emergent BioSolutions Gearing Up To Mass-Produce Future COVID-19 VaccineA Baltimore-based company is gearing up to mass-produce a COVID-19 vaccine once it's approved.
Emergent BioSolutions Signs $174M Agreement To Expand Production Of Possible Coronavirus VaccineA Maryland-based company has signed a $174 million agreement to expand production of a coronavirus vaccine candidate.